Skip to main content

Animations

MJFF Publications

7371 - 7380 of 8819 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2025
  • 2024
  • 2024
  • 2022
  • 2022
  • 2022
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: A unifying model for the role of the ATG8 system in autophagy
    Journal Name: Journal of Cell Science
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1242/jcs.258997
    Citation Count: 23
  • Summary Details
    OPEN
    Title: PINK1: From Parkinson’s disease to mitophagy and back again
    Journal Name: PLOS Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pbio.3002196
    Citation Count: 11
  • Summary Details
    OPEN
    Title: BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating Triglycerides
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c03046
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Cardiac sympathetic denervation and anxiety in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106997
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glands
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A step forward for LRRK2 inhibitors in Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abq7374
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Unaltered T cell responses to common antigens in individuals with Parkinson's disease
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jns.2022.120510
    Citation Count: 15
  • Summary Details
    OPEN
    Title: The complex role of inflammation and gliotransmitters in Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Spatially heterogeneous structure-function coupling in haemodynamic and electromagnetic brain networks
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.120276
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.